HEMATOLOGY
Latest News
November 27th 2024
LBS-007, a novel targeted therapy, has received FDA fast track designation for the treatment of acute myeloid leukemia.
November 25th 2024
November 15th 2024
November 14th 2024
November 12th 2024
More News
Expert Discusses Combinations, Other Research for the Treatment of Indolent Lymphomas
June 26th 2019Mitchell Smith, MD, PhD, discussed the most recent research and agents under investigation for the treatment of indolent lymphomas. He also highlighted how conversations transpire when discussing the watch-and-wait approach with his asymptomatic patients.
Read More
Relapsed/Refractory PMBCL Shows High Response Rate to Nivolumab and Brentuximab Vedotin
June 24th 2019A combination of nivolumab plus brentuximab vedotin was highly active in 73% of patients with relapsed/refractory primary mediastinal large B-cell lymphoma, based on results from the phase I/II CheckMate 436 trial, recently announced during the 15th International Conference on Malignant Lymphoma.<br />
Read More
